Birdwatch Archive

Birdwatch Note Rating

2023-10-02 18:58:27 UTC - HELPFUL

Rated by Participant: 9524EAA662F40D6049973C639E928E70801A4C072C4CCBD9B4D4548F3540CA16
Participant Details

Original Note:

Allogene Therapeutics was at $21.73 on Jan. 31, 2020 but doubled during Covid to $54 in May 2020. It stayed above $22 until August 2021, 1.5 years later. Selling the "stock just weeks before the coronavirus pandemic " could have caused investors to miss significant gains. https://finance.yahoo.com/quote/ALLO?p=ALLO&.tsrc=fin-srch

All Note Details

Original Tweet

All Information

  • noteId - 1708883527297651180
  • participantId -
  • raterParticipantId - 9524EAA662F40D6049973C639E928E70801A4C072C4CCBD9B4D4548F3540CA16
  • createdAtMillis - 1696273107262
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 1
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 17088835272976511809524EAA662F40D6049973C639E928E70801A4C072C4CCBD9B4D4548F3540CA16